First Trust Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,297
| Closed | -$102K | – | 2353 |
|
|
2023
Q3 | $102K | Buy |
+27,297
| New | +$102K | ﹤0.01% | 2326 |
|
|
2021
Q3 | – | Sell |
-39,093
| Closed | -$541K | – | 2534 |
|
|
2021
Q2 | $541K | Sell |
39,093
-52,678
| -57% | -$729K | ﹤0.01% | 2258 |
|
|
2021
Q1 | $1.34M | Buy |
91,771
+15,601
| +20% | +$228K | ﹤0.01% | 1885 |
|
|
2020
Q4 | $1.32M | Sell |
76,170
-12,812
| -14% | -$223K | ﹤0.01% | 1778 |
|
|
2020
Q3 | $1.63M | Buy |
+88,982
| New | +$1.63M | ﹤0.01% | 1476 |
|
|
2020
Q1 | – | Sell |
-48,741
| Closed | -$878K | – | 2365 |
|
|
2019
Q4 | $878K | Sell |
48,741
-121,006
| -71% | -$2.18M | ﹤0.01% | 1931 |
|
|
2019
Q3 | $3.44M | Buy |
169,747
+140,107
| +473% | +$2.84M | 0.01% | 1239 |
|
|
2019
Q2 | $655K | Buy |
+29,640
| New | +$655K | ﹤0.01% | 2019 |
|
|
2019
Q1 | – | Sell |
-90,645
| Closed | -$820K | – | 2413 |
|
|
2018
Q4 | $820K | Buy |
+90,645
| New | +$820K | ﹤0.01% | 1930 |
|
|
2017
Q2 | – | Sell |
-58,010
| Closed | -$1.23M | – | 2380 |
|
|
2017
Q1 | $1.23M | Sell |
58,010
-2,053
| -3% | -$43.4K | ﹤0.01% | 1776 |
|
|
2016
Q4 | $1.69M | Buy |
+60,063
| New | +$1.69M | 0.01% | 1549 |
|